(Press-News.org) CHICAGO – Modifying a patient's dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient's level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty and received a drug-releasing coronary stent, according to a study in the March 16 issue of JAMA.
Current guidelines recommend treating patients undergoing percutaneous coronary intervention (PCI; procedure such as balloon angioplasty used to open narrowed coronary arteries) and drug-eluting stent implantation with a combination of aspirin and P2Y12 (compound found on the surface of blood platelet cells and an important regulator in blood clotting) antagonist for at least 1 year. But several studies have suggested that patients with high platelet reactivity during treatment with clopidogrel are at an increased risk of cardiovascular events after PCI. A treatment strategy for this issue has not been well defined, according to background information in the article.
Matthew J. Price, M.D., of Scripps Translational Science Institute, La Jolla, Calif., and colleagues conducted the Gauging Responsiveness with A VerifyNow assay—Impact on Thrombosis And Safety (GRAVITAS) trial to determine whether high-dose clopidogrel is superior to standard-dose therapy for the prevention of cardiovascular events after PCI in patients with high on-treatment reactivity. The randomized trial included 2,214 patients with high on-treatment reactivity (measured 12 to 24 hours after PCI) with drug-eluting stents at 83 centers in North America between July 2008 and April 2010. Patients received high-dose clopidogrel (600-mg initial dose, 150 mg daily thereafter) or standard-dose clopidogrel (75 mg daily) for 6 months. The primary outcome measured was the 6-month incidence of death from cardiovascular causes, nonfatal heart attack, or stent thrombosis. Safety measurements included severe or moderate bleeding.
The researchers found that the rate of death from cardiovascular causes, nonfatal heart attack, or stent thrombosis was not different with high-dose compared with standard-dose clopidogrel in the patients with high on-treatment reactivity (25 (2.3 percent) vs. 25 [2.3 percent]). In an analysis, the event rates in the 2 groups after 30 days were (20 [1.9 percent] vs. 17 [1.6 percent]), respectively.
The reduction in on-treatment reactivity at 30 days and at 6 months after randomization was significantly greater with high-dose than with standard-dose clopidogrel. High-dose clopidogrel was associated with an absolute 22 percent lower rate of high on-treatment reactivity compared with standard-dose clopidogrel at 30 days and 6 months (40 percent vs. 62 percent; and 36 percent vs. 60 percent, respectively).
Severe or moderate bleeding was not increased with the high-dose regimen.
"In conclusion, high-dose clopidogrel for 6 months in patients with high on-treatment platelet reactivity 12 to 24 hours after PCI with drug-eluting stents did not reduce the rate of death from cardiovascular causes, nonfatal myocardial infarction, or stent thrombosis compared with standard-dose clopidogrel. The results of GRAVITAS do not support a uniform treatment strategy of high-dose clopidogrel in patients with high on-treatment reactivity identified by a single platelet function test after PCI. Alternative treatment strategies incorporating platelet function testing merit further investigation," the authors write.
(JAMA. 2011;305[11]1097-1105. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: An Initial Experiment With Personalized Antiplatelet Therapy
Paul A. Gurbel, M.D., and Udaya S. Tantry, Ph.D., of the Sinai Hospital of Baltimore, comment on the findings of this study in an accompanying editorial.
"… the GRAVITAS investigators have conducted the largest trial of personalized antiplatelet therapy thus far. The valuable information gained from the GRAVITAS trial can inform future trials. Even though GRAVITAS demonstrated that platelet function testing after drug-eluting stent placement does not improve outcomes if high-dose clopidogrel is used as the remedy, it is hoped that future studies evaluating different platelet function cutpoints and more potent P2Y12 inhibitors will be effective."
###
(JAMA. 2011;305[11]1136-1137. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.
Study examines outcomes of high-dose antiplatelet drug after stent placement
2011-03-16
ELSE PRESS RELEASES FROM THIS DATE:
Regions with higher rate of diagnoses have lower fatality rate for chronic conditions
2011-03-16
CHICAGO – An examination of data for more than 5 million Medicare beneficiaries finds that hospital regions that have a greater frequency of diagnoses have a lower case-fatality rate for chronic conditions such as coronary artery disease and kidney failure, according to a study in the March 16 issue of JAMA.
According to background information in the article, disease diagnoses are considered a critical factor in risk-adjustment policies designed to reward efficient and high-quality care. "Ideally, a diagnosis would be solely an attribute of the patient, unaffected by ...
Denver Dentist Joins Eco-Alliance
2011-03-16
Scott Greenhalgh, DDS is proud to announce that it has joined the B2B Green Alliance, an industry group that seeks to promote eco-conscious business practices among dentists and other medical and legal professionals.
The B2B Green Alliance is an environmental outreach initiative from web marketing firm Page 1 Solutions, as part of its Page 1 Green Solutions program. Page 1 Solutions strives to further reduce its environmental impact by encouraging its clients to pursue their own eco-friendly business practices and hopes to facilitate the exchange of ideas for eco-conscious ...
Evidence poor for link between biomarkers and risk of CV events for patients with kidney disease
2011-03-16
CHICAGO – Even though clinical practice guidelines for patients with chronic kidney disease recommend specific treatment target levels for serum phosphorus, parathyroid hormone, and calcium to reduce the risk of cardiovascular events, an analysis of data from previous studies did not find a strong association between these biomarkers and the risk of death and cardiovascular events, except for higher serum phosphorus levels, according to an article in the March 16 issue of JAMA.
"Nephrology guidelines recommend targets and treatment strategies to correct serum levels ...
Treatments for recurring TB infection failing the developing world, study finds
2011-03-16
The standard approach to re-treating tuberculosis (TB) in low and middle income settings is failing, according to research funded by the Wellcome Trust. In a study published today in the open access journal PLoS Medicine, researchers call for improved access to rapid diagnostics for drug resistant TB, second-line TB treatment and antiretroviral HIV therapy.
Each year, between one in ten and one in five patients treated for TB see their disease return after failing, interrupting or relapsing from treatment. This results in an estimated one million people in ninety countries ...
UCSF study predicts cholera epidemic in Haiti will far exceed UN projections
2011-03-16
A new study conducted at the University of California, San Francisco (UCSF) and Harvard Medical School predicts that the cholera epidemic in Haiti this year will be far worse than United Nations' projections, which had estimated 400,000 cases of the diarrheal disease over the course of the epidemic.
The study, to be published March 16 in the journal Lancet, is predicting instead that there could be nearly twice that number – perhaps 779,000 cases of cholera – between March and November this year alone. U.N. projections are key because they determine how resources are ...
The development of better biotech enzymes
2011-03-16
Enzymes are proteins that speed up chemical reactions, such as laundry detergent digesting protein stains, which are otherwise very difficult to remove. A research team led by Professor Kam-bo Wong of the Centre for Protein Science and Crystallography, School of Life Sciences at The Chinese University of Hong Kong demonstrated a fundamental principle in changing the activity of enzymes by means of protein engineering. The findings provide potential insights into the future design of biotechnologically important enzymes, and will be published in next week's issue of the ...
Arachnophobes beware: Hubble snaps close-up of the Tarantula
2011-03-16
The wispy arms of the Tarantula Nebula were originally thought to resemble spindly spider legs, giving the nebula its unusual name. The part of the nebula visible in this image from Hubble's Advanced Camera for Surveys is criss-crossed with tendrils of dust and gas churned up by recent supernovae. These supernova remnants include NGC 2060, visible above and to the left of the centre of this image, which contains the brightest known pulsar.
The tarantula's bite goes beyond NGC 2060. Near the edge of the nebula, outside the frame, below and to the right, lie the remains ...
Risks of Breast Augmentation
2011-03-16
It is important for you to know the possible risks associated with breast augmentation before undergoing the procedure. With the placement of a foreign object into your body, breast augmentation carries an additional set of possible complications not found in other surgical procedures.
Surgical Risks
Just like any other surgical procedure, breast augmentation carries risk factors that pose an unlikely but serious threat to your health. Some serious surgical complications include:
- Allergic reaction to anesthesia - general anesthesia carries rare but potentially ...
Social class makes no difference to water contamination risk
2011-03-16
Wealthy, well educated people who choose to drink bottled water rather than water from public supplies may be no less exposed to potentially cancer-causing water contaminants, according to new research published in BioMed Central's open access journal Environmental Health.
As part of the EPICURO national bladder cancer study, researchers from all over Spain quizzed 1,270 individuals about their water use and consumption in an effort to discover whether social class has any bearing on exposure to common water disinfection byproducts. High levels of trihalomethanes (THM), ...
Teen Cell Phone Use and Car Accidents
2011-03-16
Cell phone use is on the rise. The incidence of driving and talking or texting is too. Distracted driving and youthful drivers are two factors that have always impacted accident statistics. The combination of these two factors with the advent of the cell phone has added to an increasingly dangerous trend. Many states have already enacted legislation that place additional restrictions on youthful drivers and cell phone use. There are no such laws in the state of Georgia so even with the number of teen drivers in the greater Atlanta area no restrictions exist.
The statistics ...